GIP activation may additionally potentiate the insulin secretion effects of GLP-1 activation on the pancreas and the weight loss effects of GLP-1 activation on CNS [13]
This non-standard amino acid has a bulkier side chain than alanine, and DPP-4 simply cannot get a grip on it
Data were derived from de-identified electronic health record (EHR) extracts including medication orders, patient demographics, and longitudinal weight measurements
6 Similarly, as GLP-1RAs significantly reduced the risk of MACE, mortality from CV causes, when compared with placebo, ADA has suggested that these medications should be used in patients with underlying cardiovascular disease
Botfield HF, Uldall MS, Westgate C, Mitchell JL, Hagen SM, Gonzalez AM, et al